ROS1 and cancer: However, fluorescence <i>in situ</i> hybridization of the primary cancer showed no MET amplification, suggesting that MET amplification may be associated with an acquired resistance to ROS1-TKIs.<h4>Summary</h4>This case suggested that MET amplification could be explored as a potential mechanism for developing ROS1-TKIs resistance.